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A straightforward and robust modular synthetic approach was developed for the asymmetric synthesis of 
imidazolium salts, in which several engineered molecular vectors were considered to evaluate their 
toxicological profile. The diastereoselective synthesis of cis-3-(1H-imidazol-1-yl)cyclohexanol was 10 
achieved by the Michael addition of imidazole to cyclohex-2-en-1-one under microwave conditions 
followed by reduction of the ketone. The racemic cis-alcohol obtained was successfully resolved through 
a lipase-catalysed kinetic resolution, Pseudomonas cepacia lipase proving to be a good biocatalyst for the 
exclusive acetylation of the (1R,3S)-cis enantiomer. Using the remaining (1S,3R)-cis alcohol enantiomer 
as a synthetic precursor, the optically active (1R,3R)-trans alcohol enantiomer was also prepared. The 15 
corresponding chiral salts and ionic liquids were obtained via quaternisation reaction with alkyl halides, 
followed by anion exchange with inorganic salts. In this manner, a family of novel imidazolium-based 
ionic liquids was prepared, and its properties as phase-transfer catalysts in the Michael addition of diethyl 
malonate to trans-chalcone were analysed. The toxicity of these compounds against E. coli cells was also 
evaluated to understand their structural implications through the presented systematic synthetic approach. 20 
Introduction 
Ionic liquids are considered as valuable materials due to their 
synthetic applications as “greener” alternatives to volatile organic 
solvents1 or organocatalysts.2 Their potential application in 
synthetic transformations has been extensively studied in recent 25 
years, along with their role as stationary phases in gas 
chromatography,3 gas-liquid or liquid-liquid extractions,4 
electrochemistry,5 mass spectrometric applications,6 infrared, and 
also for Raman and fluorescence spectroscopy their use has been 
successfully demonstrated.7 The asymmetric synthesis of their 30 
chiral versions continues to be an attractive and challenging aim 
for organic chemists since chiral ionic liquids have shown great 
ability to produce significant chirality transference in 
organocatalytic reactions,8 and also due to their different physico-
chemical properties when compared to the corresponding 35 
racemates. Organic cations (e.g. imidazolium, pyridinium, 
ammonium, phosphonium) can be easily combined with a variety 
of organic or inorganic anions (e.g. halides, PF6
-, BF4
-, SbF6
-), 
leading to a myriad of possibilities to modify or finely tune the 
properties of the ionic liquid.9 Imidazolium salts are the most 40 
used common core because of their accessibility and easy 
manipulation and modification from raw materials. Nonetheless, 
toxicity measurements of ionic liquids have shown that 
imidazolium-based structures may not be the most benign.10 
 Herein, a synthetic modular approach was developed for the 45 
synthesis of various chiral imidazolium structures to further study 
their possible applications in catalytic processes and to obtain 
information on the influence of defined motifs with regards to 
their toxicity. The data thus obtained can be further used for 
preparing more ecological ionic systems. In this context, for the 50 
synthesis of a variety of chiral imidazolium salts and ionic liquids 
several key points were considered as tuneable vectors (Figure 1): 
1) the imidazole N-3 substitution (R); 2) the relative position of 
the cyclohexyl substituents and the absolute configuration of the 
stereogenic carbon atoms; and finally 3) the anion present in the 55 
molecular structure (X-). 
 
Fig. 1 Engineered molecular vectors considered for the asymmetric 
synthesis of imidazolium salts. 
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Scheme 1 Chemical synthesis and lipase-catalysed kinetic resolution of racemic alcohol cis-4. 
Results and Discussion 
Chemoenzymatic asymmetric synthesis of imidazole 
derivatives 5 
The synthesis of racemic 3-(1H-imidazol-1-yl)cyclohexanone (3) 
was previously reported from commercially available cyclohex-2-
en-1-one (1) and imidazole (2) using a Brønsted or Lewis acid, 
lanthanides, or an inorganic solid support such as cellulose, with 
moderate to high yields (63-85% yield).11 To develop a more 10 
efficient synthesis, the reaction was first carried out in the 
absence of catalyst using 1,4-dioxane or acetonitrile (MeCN) as 
solvent under reflux. Only 80% conversion was attained even 
after several days of reaction and changing the reagent ratio. 
Subsequently, the reaction was performed under microwave 15 
conditions (Scheme 1),12 and after optimisation of the power, 
temperature and reaction time, a preparative scale (300 mg) of 
imidazole (2) with an excess of ketone 1 (2 equiv.) in MeCN 
produced the racemic ketone 3 in 25 min with 98% yield after 
purification through various washes with Et2O. An up-scale of the 20 
reaction to 3 g was made, affording 96% of the pure product after 
only 2 h 30 min of microwave reaction under the same 
conditions. 
 As a first approach to selectively obtain either one of the cis- 
or trans-alcohol 4 enantiomers, a screening of alcohol 25 
dehydrogenases (ADHs)13 from Candida parapsilosis, 
Lactobacillus brevis, Lactobacillus kefir, Thermoanaerobacter 
sp., Ralstonia sp. and Rhodococcus ruber was carried out for the 
bioreduction of ketone 3 under mild reaction conditions in 
aqueous buffer. However, the products obtained were mixtures of 30 
cis- and trans-alcohol 4, along with traces of 1 and 2 due to the 
retro-Michael reaction of ketone 3 occurring in water. This 
reversibility was corroborated by dissolving ketone 3 in solvents 
such as methanol or chloroform, recovering a mixture of 1, 2 and 
3 after several hours. Consequently, the chemical reduction of 3 35 
was explored using various reducing agents to obtain only one of 
the racemic isomers as detailed in Table 1. 
Table 1 Chemical reduction of ketone 3. 
 
Entry Reducing agent Solvent T (ºC) t (h) cis/trans 4a 
1 TiCl4/BH3Py CH2Cl2 -78 2 66:33 
2 CeCl3/LiEt3BH THF -78 15 89:11 
3 LiEt3BH THF -78 15 95:5 
4 L-Selectride THF -78 15 50:50 
5 NaBH4 MeOH 0 2 85:15 
6 NaBH4 MeOH -20 5 89:11 
7 NaBH4 MeOH -78 15 95:5 
8 NaBH4 EtOH -78 15 95:5 
a Ratio calculated by 1H NMR of the reaction crude. All reactions led to 40 
full reduction of the ketone. 
 First, two different complexes formed by titanium chloride 
(IV) and pyridine borane (entry 1) or cerium chloride (III) and 
lithium triethylborohydride (entry 2) were used at -78 ºC,14 
affording good inductions towards the formation of the cis-4 45 
alcohol isomer. A considerable improvement was achieved by 
simply using LiEt3BH in THF (entry 3), obtaining a mixture of 
95:5 (90% diastereomeric excess) after 15 h favouring the cis-
isomer. A more sterically hindered reducing agent, L-Selectride, 
was also used at -78 ºC, however no stereopreference was 50 
observed (entry 4). Sodium borohydride (NaBH4) was used in 
MeOH at different temperatures (0 to -78 ºC, entries 5-7), and as 
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expected, higher cis/trans ratios were observed at lower 
temperatures, affording alcohol 4 in moderate to excellent 
diastereomeric excess (70% at 0 ºC, 78% at -20 ºC and 90% at     
-78 ºC). The best selectivity was thus reached at lower 
temperatures, with no difference observed with ethanol as solvent 5 
(entry 8). An up-scale (5 g) of the reaction was performed with 
NaBH4, because of its easier handling, higher stability and lower 
cost with respect to LiEt3BH, without any loss of selectivity, 
affording alcohol 4 with 98% yield and 90% dr. Separation of 
cis- and trans-4 isomers was not possible by column 10 
chromatography, so the mixture was later recrystallised in 
dichloromethane yielding the racemic cis-alcohol in 74% yield 
and >99% dr (Scheme 1). 
Table 2 Lipase-catalysed kinetic resolution of (±)-cis-4 using 
THF as solvent, 3 equiv. of vinyl acetate, at 30 ºC and 250 rpm. 15 
 
Entry Enzyme t (h) eeS (%)
a eeP (%)
a c (%)b Ec 
1 CAL-B 1 82 88 48 40 
2 CAL-B 2 >99 84 54 87 
3 PCL-C I 23 98 (83) 96 (95) 50 >200 
4 PCL IM 23 99 (98) 97 (98) 50 >200 
5 PCL SD 23 8 >99 8 >200 
a Enantiomeric excess (eeS for alcohol; eeP for acetate) determined by 
HPLC. Isolated yields in parenthesis. b Conversion: c = eeS / (eeS + eeP). 
c Enantiomeric ratio: E = ln[(1 - c)  (1 - eeS)] / ln[(1 - c)  (1 + eeS)]. 
 Biocatalytic asymmetric methodologies such as kinetic 20 
resolutions (KRs), dynamic kinetic resolutions (DKRs) or 
enantioselective desymmetrisations (EDs) are very solicited 
processes for academic and industrial purposes.15 Among all 
known enzymes, hydrolases and mainly lipases have attracted 
considerable attention due to their commercial availability and 25 
multiple applications in chemo-, regio- or stereoselective 
processes.16 With poor selectivities obtained in the bioreduction 
of racemic 3-(1H-imidazol-1-yl)cyclohexanone 3 and because of 
the retro-Michael reaction occurring in solution, the lipase-
catalysed kinetic resolution of the racemic cis-alcohol 4 was 30 
explored to obtain enantiomerically pure products. Employing 
anhydrous THF as solvent, vinyl acetate as acyl donor (VinOAc, 
3 equiv.) and a temperature of 30 ºC,17 the influence of the lipase 
in the KR process was studied by screening the enzymes Candida 
antarctica lipase B (CAL-B) and different preparations of 35 
Pseudomonas cepacia lipase (PCL, also currently known as 
Burkholderia cepacia lipase). While the reaction with CAL-B 
was extremely fast, yielding the (1S,3R)-alcohol 4 in enantiopure 
form after only 2 h and 54% conversion (entries 1 and 2, Table 
2), all PCL preparations led to the stereoselective formation of 40 
the (1R,3S)-acetate 5 in high ee. Both lipases supported on 
ceramic (PCL-C I, entry 3) or immobilised on diatomaceous earth 
(PCL IM, entry 4) reached 50% conversion after 23 h leading to 
almost enantiopure substrate (99% ee) and product (97% ee). Not 
surprisingly, PCL SD attained a lower conversion (8%, entry 5), 45 
as this preparation is more suited for aqueous medium. Therefore, 
the PCL IM was identified as the best biocatalyst for the lipase-
catalysed resolution of racemic cis-alcohol 4 (Scheme 1). 
Furthermore, after chemical hydrolysis of the acetyl group of 
(1R,3S)-5 with K2CO3 in MeOH, the alcohol enantiomer (1R,3S)-50 
4 was obtained without any loss of its optical purity (97% ee). 
 For trans-alcohol 4, since only the cis-alcohol 4 could be 
obtained with the explored methods, the Mitsunobu reaction18 
was performed on the racemic cis-alcohol 4. Thus, p-nitrobenzoic 
acid, diethyl azadicarboxylate (DEAD) and triphenylphosphine in 55 
anhydrous THF were employed, and the formed ester was 
deprotected with sodium methoxide at room temperature yielding 
the racemic trans-alcohol 4 in 51% overall yield (Scheme 2). 
 
Scheme 2 Synthesis and lipase-catalysed KR of (±)-trans-alcohol 4. 60 
 Biocatalysed kinetic resolution of the racemate was attempted 
to give access to both enantiomers (1S,3S)-trans-alcohol 4 and 
(1R,3R)-trans-acetate 5 (Table 3). Unfortunately, low selectivity 
and reactivity were obtained with CAL-B (entries 1 and 2) while 
PCL-C I required 60 ºC to attain 23% conversion of the acetate in 65 
enantiopure form (entry 3). However, longer reaction times did 
not lead to increased conversion. In addition, more drastic 
conditions such as using the acyl donor (VinOAc) as reaction 
medium provoked a dramatic loss in the stereoselectivity of the 
process (entry 4). Therefore, an alternative chemoenzymatic 70 
approach for the synthesis of (1R,3R)-trans-4 was developed. 
Hence, starting from enantioenriched (1S,3R)-cis-alcohol 4, the 
optically active (1R,3R)-trans-alcohol 4 was obtained following a 
Mitsunobu inversion/deprotection sequence, as previously 
described for the racemic trans-4 in Scheme 2. 75 
Table 3 Lipase-catalysed kinetic resolution of (±)-trans-alcohol 4 using vinyl acetate (VinOAc) and 250 rpm. 
Entry Enzyme Solvent VinOAc T (ºC) t (h) eeS (%)
a eeP (%)
a c (%)b Ec 
1 CAL-B THF 3 equiv. 30 169 17 63 21 5 
2 CAL-B THF 3 equiv. 60 23 23 31 43 3 
3 PCL-C I THF 3 equiv. 60 23 29 >99 23 >200 
4 PCL-C I VinOAc 0.1 M 60 23 37 28 57 2 
a Enantiomeric excess (eeS for alcohol; eeP for acetate) determined by HPLC. 
b Conversion: c = eeS / (eeS + eeP). 
c Enantiomeric ratio: E = ln[(1 - c)  (1 - eeS)] / ln[(1 - c)  (1 + eeS)]. 
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Scheme 3 Synthesis of imidazolium salts and ionic liquids through quaternisation and anion exchange chemical sequence. 
 
Preparation of chiral ionic imidazolium salts and ionic liquids 
Having in hand the adequate optically active pure precursors for 5 
the synthesis of the imidazolium salts, a general synthetic 
sequence based on the quaternisation of the N-3 imidazole 
nitrogen atom and subsequent anion exchange to modulate the 
physico-chemical properties of the ionic salt was developed in a 
similar manner as previously reported for the synthesis of 1,2-10 
derivatives.19 The fine tuning of ionic liquids properties through 
structural design not only opens new possibilities for their use in 
different applications, but also enables the study of critical factors 
applied to Sustainable Chemistry that can affect their toxicity. 
Herein, structural diversity (Figure 1) was considered based on 15 
the counter-anion (Br-, Cl-, BF4
-, NTf2
- or Pro-), the imidazolium 
alkylating chain (Bn, n-Bu or n-Oct) and the configuration of the 
two stereogenic centres including their relative disposition (cis or 
trans). Hence, the nomenclature of the salts was defined by the 
following descriptors: the first one includes the absolute 20 
configuration of C1 and C3 at the cyclohexyl ring [i.e., (R,S)-]. 
The relative configuration at these carbon atoms is reported by 
the second descriptor trans or cis [i.e., (R,S)-cis-]. The term IM 
refers to an imidazole derivative [i.e., (R,S)-cis-IM-]. The fourth 
descriptor indicates the presence of OH at C1 of the ring [i.e., 25 
(R,S)-cis-IM-OH-]. The nature of the alkyl chain at N-3 of the 
imidazolium moiety is indicated by the use of Bn (benzyl), Bu (n-
butyl) or Oct (n-octyl) [i.e., (R,S)-cis-IM-OH-Bn-]. Finally the 
last descriptor refers to the anion [i.e., (R,S)-cis-IM-OH-Bn-Br]. 
 The synthesis of the chiral imidazolium salts and ionic liquids 30 
was carried out starting from both racemic and optically active 
cis- and trans-alcohol 4, by reaction with alkyl or benzyl halides 
at 70 or 100 ºC for the mono-quaternisation of the N-3 position 
(Scheme 3). Brominated salts were prepared using a small excess 
of the alkylating agent (1.2 equiv.), with a larger excess (10 35 
equiv.) and longer reaction time for chloride salts, yielding the 
desired halide salts in good to excellent yields (82-98%) after 
successive washes with Et2O. In addition, the quaternisation 
reaction time could be shortened under microwave conditions 
(0.5-1 h). 40 
 Exchange of the halide anion was possible using inorganic 
salts such as lithium bis(trifluoromethane sulfonimide) (LiNTf2) 
or sodium tetrafluoroborate (NaBF4), obtaining yields between 74 
to 98% after 24 h at room temperature. In an attempt to prepare 
proline-derived organocatalysts, reactions of halide salts with 45 
potassium prolinate generated in situ from proline and potassium 
hydroxide were carried out. The corresponding prolinate salts 
were smoothly formed, however their poor solubility in organic 
solvents and the formation of potassium bromide during the anion 
exchange in water made their purification impossible. An 50 
alternative strategy was envisaged using the chloride salts as 
starting material. Anion exchange of IM-OH-R-Cl with basic 
Amberlite IRA-440-OH resin led to the corresponding IM-OH-R-
OH intermediates,20 to which L-proline was subsequently added, 
affording IM-OH-R-Pro in good to excellent yields (82-98%). 55 
 
Fig. 2 Solid-state structure of the imidazolium salt (1S,3R)-cis-
IM-OH-Bn-Br determined through an X-ray diffraction analysis. 
 Moreover, the optically active compound (1S,3R)-cis-IM-OH-
Bn-Br was successfully crystallised and solved by single crystal 60 
X-ray diffraction, revealing the absolute configuration of their 
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stereogenic centres and confirming the selective quaternisation at 
the N-3 atom suggested by NMR studies. The solid-state structure 
(Figure 2) corroborated the lipase-catalysed acetylation at the 
(1R)-position of cis-alcohol 4,21 in accordance with the 
stereopreference observed for CAL-B and PCL in the lipase-5 
catalysed acetylation towards other 1,3-amino alcohols.22 
Consequently, after a Mitsunobu inversion/deprotection reaction, 
the configuration of (1R,3R)-trans-alcohol 4 was also confirmed. 
Once both racemic and optically active salts were obtained, their 
possible use in organocatalysis was explored by using them as 10 
phase transfer catalysts in the model reaction of Michael addition 
of diethyl malonate to trans-chalcone, and their inhibition 
properties in the growth of E. coli cells were also evaluated as a 
test of their biocompatibility. 
Application of imidazolium salts and ionic liquids in a 15 
Michael-type addition reaction 
Asymmetric phase-transfer catalysts (APTC) are recognised as 
powerful tools due to their chirality transfer abilities, encouraging 
the development of different systems over the past years.23 
Recently, enantiopure triazolium salts were employed as APTC 20 
in the Michael addition between diethyl malonate (6) and trans-
chalcone (7),24 so the potential use of the above synthesised 1H-
imidazol-3-ium salts in this catalytic process was envisioned. The 
reactions were performed using dry potassium carbonate, 
observing only trace amounts of the final adduct (±)-8 in the 25 
absence of the catalyst. The results using the salts and ILs as 
catalysts in this reaction are summarised in Table 4. As can be 
seen, generally good to excellent conversions were achieved 
although with low stereoselectivities, varying the absolute 
configuration of the final product depending on the disposition of 30 
the substituents in the cyclohexyl ring. 
 Clear trends could be observed, for instance octyl derivatives 
led to higher activity values compared to benzyl or butyl ones, 
and all derivatives afforded conversions over 89% (entries 1-3, 5-
7 and 8-10) except when prolinate was the anion (entries 17-19). 35 
While racemates led to adduct 8 with no enantiopreference 
(entries 11 and 16), optically active catalysts gave low, albeit 
appreciable, selectivities (entries 12 and 17), usually favouring 
the (R)-product for cis-catalysts while (S)-8 was preferentially 
obtained when employing trans-derivatives (entries 4 and 20). 40 
Bistrifluoromethane sulfonimides showed poorer activity values 
(13-28% conversion, entries 14 and 15), while chlorides and 
tetrafluoroborates led to excellent levels of conversion (entries 5-
10 and 12-13). Finally, the effect of proline-derived catalysts is 
remarkable, because while adding L-proline to the reaction no 45 
conversion was observed, pleasingly all the prolinate salts 
catalysed the formation of the final product in moderate to good 
conversions (entries 17-20). 
 In summary, the structural features of the organocatalyst 
employed influenced the outcome of the Michael addition 50 
reaction, highlighting the importance of modular synthetic 
approaches for the synthesis of chiral catalysts. In general, 
excellent levels of activity were achieved with halogenated salts 
and tetrafluoroborate ionic liquids, obtaining the highest 
stereoselectivities, although very low for synthetic purposes, with 55 
the prolinate and chloride imidazolium compounds. Finally, 
racemates obviously did not induce any chirality and most 
remarkably, a reversed stereospecificity was achieved when 
changing the absolute configuration of the stereogenic centres. 
Table 4 Michael addition reaction between diethyl malonate (6) 60 
and trans-chalcone (7) using dry potassium carbonate and 
imidazolium ionic derivatives at 25 ºC. 
 
Entry Catalyst c (%)a eeP (%)
b 
1 (+)-(1R,3S)-cis-IM-OH-Bn-Br 89 <3 
2 (+)-(1R,3S)-cis-IM-OH-Bu-Br 89 <3 
3 (+)-(1R,3S)-cis-IM-OH-Oct-Br 98 <3 
4 (–)-(1R,3R)-trans-IM-OH-Bn-Br 20 5 (S) 
5 (–)-(1S,3R)-cis-IM-OH-Bn-Cl 95 6 (R) 
6 (–)-(1S,3R)-cis-IM-OH-Bu-Cl >99 6 (R) 
7 (–)-(1S,3R)-cis-IM-OH-Oct-Cl >99 6 (R) 
8 (+)-(1R,3S)-cis-IM-OH-Bn-Cl 90 <3 
9 (+)-(1R,3S)-cis-IM-OH-Bu-Cl 98 <3 
10 (+)-(1R,3S)-cis-IM-OH-Oct-Cl 98 <3 
11 (±)-cis-IM-OH-Bn-BF4 76 0 
12 (–)-(1S,3R)-cis-IM-OH-Bn-BF4 97 7 (R) 
13 (–)-(1R,3R)-trans-IM-OH-Bn-BF4 99 <3 
14 (–)-(1S,3R)-cis-IM-OH-Bn-NTf2 28 <3 
15 (–)-(1R,3R)-trans-IM-OH-Bn-NTf2 13 <3 
16 (±)-cis-IM-OH-Bn-Pro 67 0 
17 (–)-(1S,3R)-cis-IM-OH-Bn-Pro 78 8 (R) 
18 (–)-(1S,3R)-cis-IM-OH-Bu-Pro 60 6 (R) 
19 (–)-(1S,3R)-cis-IM-OH-Oct-Pro 83 4 (R) 
20 (–)-(1R,3R)-trans-IM-OH-Bn-Pro 87 3 (S) 
a Determined by 1H NMR of the reaction crude. b Determined by HPLC. 
Biological evaluation of imidazolium salts and ionic liquids 65 
through the agar diffusion test 
The choice of reactants and solvents is of particular interest, 
especially when considering an up-scale of a reaction. In this 
respect, a realistic view of the eco-toxicity parameters must be 
considered.25 The agar diffusion test is a simple and effective 70 
method to screen the toxicity caused by ionic liquids based on 
their ability to inhibit the growth of a determined 
microorganism.26 The absence of sophisticated equipment and the 
use of inexpensive medium appear as clear advantages for the 
development of this method. In order to further employ the 75 
imidazolium salts for biocatalytic purposes in the near future, and 
because nowadays many bacterial enzymes can be easily cloned 
and over-expressed on E. coli as host microorganism, this 
bacterium was chosen as a suitable model to study their 
biocompatibility. Therefore, E. coli cells were spread onto LB 80 
agar plates, and a filter paper disc was soaked with the 
corresponding imidazolium alcohol, salt or ionic liquid and 
placed on the lawn of cells. All plates were incubated for 24 h at 
30 ºC, and the inhibition zone around the filter paper was 
measured. Data are compiled in Table 5. 85 
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Table 5 Measurement of the inhibition of E. coli cells growth caused by imidazolium compounds after incubation at 30 ºC during 24 h. 
Entry Compound Amount of compound 
(mol) 
Inhibition zone (mm) Normalised inhibition zone 
(mm/µmol) 
1 Blank ---- 0 0 
2 (±)-IM-cis-OH 0.0126 0 0 
3 (±)-trans-IM-OH-Bn-Br 0.0152 4.5 296 
4 (±)-cis-IM-OH-Bn-Br 0.0170 3 176 
5 (–)-cis-(1S,3R)-IM-OH-Bn-Br 0.0246 8 325 
6 (+)-cis-(1R,3S)-IM-OH-Bn-Br 0.0187 14 749 
7 (±)-cis-IM-OH-Bu-Br 0.0300 2 67 
8 (–)-cis-(1S,3R)-IM-OH-Bu-Br 0.0284 2 71 
9 (+)-cis-(1R,3S)-IM-OH-Bu-Br 0.0330 2 61 
10 (±)-cis-IM-OH-Oct-Br 0.0171 11.5 673 
11 (–)-cis-(1S,3R)-IM-OH-Oct-Br 0.0053 4 757 
12 (+)-cis-(1R,3S)-IM-OH-Oct-Br 0.0206 5.5 267 
13 (±)-trans-IM-OH-Bn-Cl 0.0114 4.5 395 
14 (±)-cis-IM-OH-Bn-Cl 0.0256 5 195 
15 (±)-cis-IM-OH-Bu-Cl 0.0213 2 94 
16 (±)-cis-IM-OH-Oct-Cl 0.0130 12.25 938 
17 (±)-trans-IM-OH-Bn-BF4 0.0257 6.5 253 
18 (±)-cis-IM-OH-Bn-BF4 0.0081 1.25 154 
19 (±)-cis-IM-OH-Bu-BF4 0.0190 1.75 92 
20 (±)-cis-IM-OH-Oct-BF4 0.0131 12.5 954 
21 (±)-trans-IM-OH-Bn-NTf2 0.0067 5 746 
22 (±)-cis-IM-OH-Bn-NTf2 0.0085 2 235 
23 (±)-cis-IM-OH-Bu-NTf2 0.0117 2.5 214 
24 (±)-trans-IM-OH-Bn-Pro 0.0051 1 196 
25 (±)-cis-IM-OH-Bn-Pro 0.0142 2.25 158 
26 (±)-cis- M-OH-Bu-Pro 0.0226 2 88 
27 (±)-cis-IM-OH-Oct-Pro 0.0133 10.5 798 
 
 The toxicity measurements were performed taking into account 
the µmoles used for each substrate in order to compare the effect 
of the imidazole derivatives on the inhibition of the E. coli cells 5 
growth. In all cases, the perfect water-miscibility of the salts and 
ILs tested allowed a good diffusion through the agar plate. 
Furthermore, no precipitate or chemical reaction in the paper disc 
was observed as previously mentioned for other ionic 
compounds.26 In the case of the blank experiment without IL, no 10 
inhibition growth was observed. Representative photos are shown 
in Figure 3. 
 Defined trends were clearly observed in Table 5 and are more 
detailed in Tables S1-S4 in the ESI. While bistrifluoromethane 
sulfonimide-derived imidazolium compounds behaved as the 15 
more toxic ILs (Table S1), bromide and proline derivatives 
generally were the ones that led to lower toxicity values. The 
longer the cation alkyl chain length was, the lower the 
biocompatibility was, as previously observed by Frade et al. (n-
Bu < Bn < n-Oct).27 Thus, octyl derivatives clearly reached the 20 
highest values for the inhibition of E. coli cells growth (Table 
S2). 
 
Fig. 3 Agar diffusion tests for a series of imidazolium compounds. Left 
plate: top from left (±)-cis-IM-OH-Bn-Pro; (±)-trans-IM-OH-Bn-BF4; 25 
centre (±)-cis-IM-OH-Bn-BF4; bottom from left (±)-cis-IM-OH-Bn-NTf2; 
(±)-trans-IM-OH-Bn-NTf2. Right plate: top from left: (±)-cis-OH-Oct-
Br; (+)-cis-OH-Oct-Br; bottom: (–)-cis-OH-Oct-Br. 
 Studying the effect of the relative disposition of the 
stereogenic centres was of special interest as there are few reports 30 
that evaluate this feature for ionic liquids.28 trans-Isomers led in 
all cases to higher inhibition values rather than cis-isomers (Table 
S3). Finally, an appreciable difference was observed when 
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comparing racemic and optically active compounds for the cis-
IM-OH-R-Br family (Table S4), however a clear tendency could 
not be identified, although it should be noted that the enantiomer 
toxicity effects were not cumulative. 
Conclusions 5 
In summary, a robust and straightforward approach was 
developed for the synthesis of enantiopure salts and ILs, 
combining both chemical conventional methods and biocatalytic 
reactions. Two key steps were clearly identified: 1) the selective 
reduction of ketone 3 to the racemic cis-alcohol 4 using NaBH4 at 10 
low temperature; and 2) its subsequent kinetic resolution using 
PCL IM as biocatalyst and vinyl acetate as acyl donor, thus 
enabling the preparation of the adequate building blocks for the 
synthesis of imidazolium-based ionic liquids after quaternisation 
with the corresponding alkyl halide and anion exchange with the 15 
tetrafluoroborate or bis(trifluoromethane sulfonimide) salts. 
Furthermore, an easy protocol to obtain the L-prolinate salts was 
conceived starting from the corresponding chloride salts. 
 Exploring the catalytic possibilities of the synthesised 
compounds, the Michael addition between diethyl malonate and 20 
trans-chalcone was studied with a representative range of 
imidazolium derivatives, achieving in general high activities 
although low stereopreferences. Best activities were reached with 
halogenated salts and tetrafluoroborate ionic liquids, and although 
stereoselectivities were very low for synthetic purposes, prolinate 25 
and chloride imidazolium compounds presented the highest 
values. Remarkably, a reversed stereospecificity was noticed 
when changing the absolute configuration of the stereogenic 
centres. 
 Finally, a study of the inhibited growth of E. coli cells in the 30 
presence of these derivatives enabled the identification of some 
correlations between structural motifs and the toxicity properties 
of the ionic liquids prepared, a larger cation alkyl chain length 
such as octyl, bistrifluoromethane sulfonimide anion and trans-
isomers being the less benign components. Synthesis of (chiral) 35 
ionic liquids is an important and active field nowadays, and 
researchers should think not only in the practical but also in the 
ecological implications that these derivatives show. Robust and 
flexible synthetic methods plus performance of toxicity tests for 
newly obtained ionic liquids are highly advisable for generating 40 
useful structures, rather than only collecting series of compounds 
created in many cases without additional advantages. 
Development of simple, fast and cost-effective tests such as the 
agar diffusion test should accompany these synthetic routes.29 
This test has proven to be a quick, inexpensive and reliable 45 
method that gives a clear idea about the ecological implication of 
ionic systems. 
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Experimental section 
Candida antarctica lipase type B (CAL-B, Novozyme 435, 7300 
PLU/g) was a gift from Novozymes and PCL-C I (1638 U/g) was 
purchased from Sigma-Aldrich. PCL SD (24700 U/g) is a crude 
enzyme preparation containing dextrin as diluents and PCL IM 60 
has been immobilised in diatomaceous earth (943 U/g), both were 
generously given by Amano Enzyme Europe Ltd. All other 
reagents were obtained from different commercial sources and 
used without further purification. Anhydrous solvents were dried 
over an adequate desiccant under nitrogen. Column 65 
chromatography was performed using silica gel 60 (230-240 
mesh). Melting points were obtained in open capillary tubes and 
are uncorrected. IR spectra were recorded on NaCl plates or as 
KBr pellets on a Perkin-Elmer Spectrum 100 FT-IR. 19F, 1H, 13C 
NMR, DEPT and bidimensional spectra were recorded on a 70 
Bruker NAV-300 or DPX-300 spectrometer at 282 (19F), 300 (1H) 
and 75 (13C) MHz. The chemical shifts are given in parts per 
million (ppm) and the coupling constants (J) in Hertz (Hz). Mass 
spectra (MS) were obtained by APCI+, ESI+ or ESI- on a HP1100 
chromatograph mass detector. Measurement of the optical 75 
rotation was done on a Perkin-Elmer 241 polarimeter. High 
performance liquid chromatography (HPLC) analyses were 
carried out on a Hewlett Packard 1100 chromatograph with UV 
detector at 210 nm using Daicel Chiralcel OB-H, OJ-H and 
Chiralpak AS (25 cm  4.6 mm) columns and hexane/2-propanol 80 
mixtures. Microwave reactions were carried out with a CEM 
Discover system S-Class microwave; conditions for all 
microwave reactions: temperature at 150 ºC, power at 200 W and 
pressure at 250 psi with medium to high stirring. Further detailed 
data are provided in the Electronic Supplementary Information. 85 
(±)-3-(1H-Imidazol-1-yl)cyclohexanone (3). Imidazole (2, 1.362 
g, 20.0 mmol) was dissolved in acetonitrile (10.0 mL) in a 
microwave vessel and cyclohex-2-en-1-one (1, 3.87 mL, 40.0 
mmol) was added. After 2 h and 30 min of microwave reaction 
(150 ºC, 200 w and 250 psi), the solution mixture was transferred 90 
to a round bottom flask, the solvent was evaporated under 
reduced pressure and the yellow oil was left under high vacuum. 
The resulting solid was crushed to a powder and washed with 
Et2O (3 x 10 mL) to obtain a beige fine powder (3.145 g, 96%). 
(±)-cis-3-(1H-Imidazol-1-yl)cyclohexanol (cis-4). A solution of 95 
the ketone 3 (6.50 g, 39.6 mmol) dissolved in anhydrous MeOH 
(12 mL) was cooled to -78 ºC and NaBH4 (1.05 g, 27.7 mmol) 
was added. The reaction mixture was stirred at this temperature 
for 15 h, then left to warm up at room temperature and quenched 
with HCl 1 N (5 mL). The solvent was evaporated, the product 100 
was extracted with CH2Cl2, dried over Na2SO4, filtered and 
concentrated under reduced pressure to afford the pure product as 
a white powder (6.419 g, 98%) with a cis/trans ratio of 95:5 (90% 
dr) as measured by 1H NMR. After recrystallisation from CH2Cl2, 
the desired racemic alcohol diastereomer cis-4 was obtained as 105 
white solid crystals (>99% dr, 4.686 g, 74%). 
(±)-cis-3-(1H-Imidazol-1-yl)cyclohexyl acetate (cis-5). To a 
solution of DMAP (14.7 mg, 0.12 mmol) and Ac2O (228 μL, 2.41 
mmol) in anhydrous CH2Cl2 (15 mL), the alcohol 4 (200 mg, 1.20 
mmol) and Et3N (507 μL, 3.61 mmol) were added. The reaction 110 
mixture was stirred for 30 min, the solvent was then evaporated 
and the crude was purified by column chromatography (5% 
MeOH / CH2Cl2), affording the pure product (237 mg, 95%) as a 
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clear yellow oil. 
PCL IM catalysed kinetic resolution of (±)-cis-4 through 
acetylation reaction. To a solution of (±)-cis-4 (1.0 g, 6.0 mmol) 
and PCL IM (1.0 g) in anhydrous THF (60 mL), vinyl acetate 
(1.664 mL, 18.0 mmol) was added and the reaction mixture was 5 
left in an orbital shaker at 250 rpm and 30 °C. The reaction was 
followed by taking aliquots at regular intervals and analysed by 
HPLC. After 23 h, 50% conversion was obtained and the reaction 
was stopped by filtering the enzyme out and washing it with 
CH2Cl2 (3 x 5 mL). The solvent was then evaporated under 10 
reduced pressure and the crude was purified by column 
chromatography (5-10% MeOH / CH2Cl2), obtaining the alcohol 
(1S,3R)-4 (492 mg, 98%, 99% ee) as a white powder and the 
acetate (1R,3S)-5 (614 mg, 98%, 97% ee) as a clear yellow liquid. 
(1R,3S)-cis-3-(1H-Imidazol-1-yl)cyclohexanol (cis-4). Acetate 15 
(1R,3S)-5 (2.50 g, 12.0 mmol) was dissolved in MeOH (12 mL) 
and K2CO3 (4.976 g, 36.0 mmol) was added. The mixture was 
stirred overnight at room temperature, then the solvent was 
evaporated and the crude was purified by flash column 
chromatography (10% MeOH / CH2Cl2) to obtain the alcohol 20 
(1R,3S)-4 as a pure white powder (1.95 g, 98%, 97% ee). 
(±)- or (1R,3R)-trans-3-(1H-Imidazol-1-yl)cyclohexanol (trans-
4). To a solution of the alcohol (±)-cis-4 (500 mg, 3.01 mmol) in 
anhydrous THF (15 mL), para-nitrobenzoic acid (1.005 g, 6.02 
mmol) and triphenylphosphine (1.578 g, 6.02 mmol) were added. 25 
Diethyl azodicarboxylate (DEAD) (1.084 mL, 6.02 mmol) was 
added dropwise leaving a clear yellow solution. The reaction 
mixture was stirred at room temperature for 2 h. Then, the solvent 
was evaporated and a solution of NaOMe (15 mL) was added. 
The reaction was stirred at room temperature for 2 h. Afterwards, 30 
the solvent was evaporated and the crude was purified by column 
chromatography (5% MeOH / CH2Cl2), affording the pure 
product (255 mg, 51%) as a white powder. 
General procedure for the synthesis of bromide salts (IM-
OH-R-Br). To a solution of the alcohol 4 (200 mg, 1.20 mmol) 35 
in acetonitrile (1 mL), the corresponding halide (1.44 mmol) was 
added inside a sealed tube. The reaction mixture was stirred at 70 
ºC for 2 h 30 min (for BnBr) or at 100 ºC for 24 h (for n-BuBr 
and n-OctBr) in a sand bath and then cooled to room temperature. 
Et2O (5 mL) was added and the resulting white solid precipitate 40 
was further washed with Et2O (3 x 10 mL) to remove the excess 
of unreacted halide, thus obtaining the corresponding bromide 
salts (98% in all cases) as white powders. 
General procedure for the synthesis of IM-OH-Bn-Cl. To a 
solution of the alcohol 4 (200 mg, 1.20 mmol) in acetonitrile (1 45 
mL), benzyl chloride (1.384 mL, 12.0 mmol) was added in a 
sealed tube. The reaction mixture was stirred at 70 ºC in a sand 
bath for 7 h and then cooled to room temperature. Et2O (5 mL) 
was added and the resulting white solid precipitate was further 
washed with Et2O (3 x 10 mL) to obtain IM-OH-Bn-Cl (352.2 50 
mg, 98%) as a white powder. 
General procedure for the synthesis of IM-OH-R-Cl (R= Bu, 
Oct). To a solution of the alcohol 4 (450 mg, 2.71 mmol) in 
acetonitrile (2 mL), the corresponding halide (27.1 mmol) was 
added. The reaction was done using microwave conditions in 1 h. 55 
Et2O (5 mL) was added and the resulting clear colourless oil was 
further washed with Et2O (3 x 10 mL) to remove the excess of 
unreacted chloride, obtaining IM-OH-R-Cl (82-90%) as a clear 
colourless oil. 
General procedure for the anion exchange reaction in the 60 
synthesis of IM-OH-R-X (R= Bn, Bu, Oct; and X= BF4, NTf2). 
A solution of LiNTf2 or NaBF4 (0.445 mmol) in H2O (300 μL) 
was added to a solution of the bromide salt IM-OH-R-Br (0.297 
mmol) in MeOH (7.0 mL) and the reaction mixture was stirred 
for 24 h at room temperature. The solvent was then evaporated 65 
under reduced pressure and the product was extracted with 
CH2Cl2 (3 x 10 mL), dried over Na2SO4 and concentrated to 
afford the corresponding IM-OH-R-X salt (74-98%). 
General procedure for the anion exchange reaction in the 
synthesis of IM-OH-R-Pro (R= Bn, Bu, Oct). The 70 
corresponding chloride salt IM-OH-R-Cl (0.512 mmol) was 
dissolved in distilled H2O (5.0 mL) and two scoops of Amberlite 
IRA-440-OH resin (previously washed with distilled water and 
methanol) were added. The mixture was stirred for 5 min, then 
the resin was filtered out and L-proline (70.8 mg, 0.615 mmol) 75 
was added to the solution. The reaction mixture was stirred at 
room temperature for 24 h. The solvent was then evaporated 
under reduced pressure and the oil was left under high vacuum. 
The oil was then dissolved in minimal amounts of 10% MeOH / 
MeCN and the resulting precipitate observed was filtered out 80 
with a short pipette cotton plug, thus removing any excess of 
proline. The solvent was evaporated and the product dried under 
high vacuum for 48 h, obtaining a clear light yellow oil (82-
98%). 
General procedure for the Michael addition of diethyl 85 
malonate to trans-chalcone catalysed by imidazolium salts. 
Imidazolium salt IM-OH-R-X (0.036 mmol, 0.5 equiv), trans-
chalcone (7, 15 mg, 0.072 mmol, 1 equiv.), dry K2CO3 (30 mg, 
0.216 mmol, 3 equiv.) and diethyl malonate (6, 13 µL, 0.086 
mmol, 1.2 equiv.) were dissolved using a mixture of CH2Cl2 / 90 
toluene (300 / 60 µL) in an eppendorf tube. The mixture was 
stirred on an orbital shaker at 900 rpm and 25 ºC for 24 h. Once 
the reaction was stopped, the conversion value was calculated by 
1H-NMR of the reaction crude. The enantiomeric excess of the 
final product was calculated by HPLC with the chiral column 95 
Chiralpak IA at 40 ºC n-hexane:EtOH (95:5) as eluent with a 
flow of 0.8 mL/min: tR = 14.5 min for the (S)-8 enantiomer and 
17.1 min for the (R)-8 enantiomer. 
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